Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells

Abstract Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) is a potential redox agent in cells. The present study investigated changes in cellular reactive oxygen species (ROS) and glutathione (GSH) levels and in antioxidant enzymes, in Tempol-treated Calu-6 and A549 lung cancer cells, normal...

Full description

Bibliographic Details
Main Author: Woo Hyun Park
Format: Article
Language:English
Published: Nature Portfolio 2021-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-94340-z
_version_ 1818834655258869760
author Woo Hyun Park
author_facet Woo Hyun Park
author_sort Woo Hyun Park
collection DOAJ
description Abstract Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) is a potential redox agent in cells. The present study investigated changes in cellular reactive oxygen species (ROS) and glutathione (GSH) levels and in antioxidant enzymes, in Tempol-treated Calu-6 and A549 lung cancer cells, normal lung WI-38 VA-13 cells, and primary pulmonary fibroblasts. Results demonstrated that Tempol (0.5–4 mM) either increased or decreased general ROS levels in lung cancer and normal cells at 48 h and specifically increased O2 •− levels in these cells. In addition, Tempol differentially altered the expression and activity of antioxidant enzymes such as superoxide dismutase, catalase, and thioredoxin reductase1 (TrxR1) in A549, Calu-6, and WI-38 VA-13 cells. In particular, Tempol treatment increased TrxR1 protein levels in these cells. Tempol at 1 mM inhibited the growth of lung cancer and normal cells by about 50% at 48 h but also significantly induced cell death, as evidenced by annexin V-positive cells. Furthermore, down-regulation of TrxR1 by siRNA had some effect on ROS levels as well as cell growth inhibition and death in Tempol-treated or -untreated lung cells. In addition, some doses of Tempol significantly increased the numbers of GSH-depleted cells in both cancer cells and normal cells at 48 h. In conclusion, Tempol differentially increased or decreased levels of ROS and various antioxidant enzymes in lung cancer and normal cells, and induced growth inhibition and death in all lung cells along with an increase in O2 •− levels and GSH depletion.
first_indexed 2024-12-19T02:38:16Z
format Article
id doaj.art-d8c46cc274cb45c498ea690ce243b174
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T02:38:16Z
publishDate 2021-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-d8c46cc274cb45c498ea690ce243b1742022-12-21T20:39:16ZengNature PortfolioScientific Reports2045-23222021-07-0111111210.1038/s41598-021-94340-zTempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cellsWoo Hyun Park0Department of Physiology, Medical School, Jeonbuk National UniversityAbstract Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) is a potential redox agent in cells. The present study investigated changes in cellular reactive oxygen species (ROS) and glutathione (GSH) levels and in antioxidant enzymes, in Tempol-treated Calu-6 and A549 lung cancer cells, normal lung WI-38 VA-13 cells, and primary pulmonary fibroblasts. Results demonstrated that Tempol (0.5–4 mM) either increased or decreased general ROS levels in lung cancer and normal cells at 48 h and specifically increased O2 •− levels in these cells. In addition, Tempol differentially altered the expression and activity of antioxidant enzymes such as superoxide dismutase, catalase, and thioredoxin reductase1 (TrxR1) in A549, Calu-6, and WI-38 VA-13 cells. In particular, Tempol treatment increased TrxR1 protein levels in these cells. Tempol at 1 mM inhibited the growth of lung cancer and normal cells by about 50% at 48 h but also significantly induced cell death, as evidenced by annexin V-positive cells. Furthermore, down-regulation of TrxR1 by siRNA had some effect on ROS levels as well as cell growth inhibition and death in Tempol-treated or -untreated lung cells. In addition, some doses of Tempol significantly increased the numbers of GSH-depleted cells in both cancer cells and normal cells at 48 h. In conclusion, Tempol differentially increased or decreased levels of ROS and various antioxidant enzymes in lung cancer and normal cells, and induced growth inhibition and death in all lung cells along with an increase in O2 •− levels and GSH depletion.https://doi.org/10.1038/s41598-021-94340-z
spellingShingle Woo Hyun Park
Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
Scientific Reports
title Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_full Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_fullStr Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_full_unstemmed Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_short Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_sort tempol differently affects cellular redox changes and antioxidant enzymes in various lung related cells
url https://doi.org/10.1038/s41598-021-94340-z
work_keys_str_mv AT woohyunpark tempoldifferentlyaffectscellularredoxchangesandantioxidantenzymesinvariouslungrelatedcells